Retracted: Predictors of COVID-19 vaccine hesitancy in Germany: a cross-sectional, population-based study

Umakanthan, Srikanth; Lawrence, Sam

doi:10.1136/postgradmedj-2021-141365

Cited by 66 publications

(74 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Medical considerations such as the vaccine’s novelty and medical preconditions seemed to have an effect on the willingness to get vaccinated [ 11 ]. In addition, other factors outside the range of medical-related concerns contributed to the likelihood of getting vaccinated, including educational degree, adherence to COVID-19-related measures, age, sex, the source of COVID-19-related information, and trust in authorities [ 12 , 13 , 14 , 15 , 16 ].…”

Section: Introductionmentioning

confidence: 99%

COVID-19 Vaccine for Children: Vaccination Willingness of Parents and Its Associated Factors—A Network Analysis

et al. 2022

View full text Add to dashboard Cite

Different COVID-19 vaccines have been approved for underage children, so parents and caregivers currently face the decision of whether to vaccinate their children against COVID-19 or not. Due to the rather moderate vaccine acceptance among parents across different countries, the objective of the present study was to investigate the relationship between different psychological, demographic, and behavioral factors related to the acceptance of the COVID-19 vaccine for underage children among parents. In particular, vaccination attitudes, whether parents have been vaccinated against COVID-19 themselves, COVID-19 fear, attitude towards COVID-19 policy measures, governmental trust, subjective level of information, perceived risk of disease progression, and perceived risk of vaccine side effects were the variables of interest. The study adopted a cross-sectional study design, and the sample consisted of 2405 participants. A network analysis was conducted to investigate the associations and interconnection among these variables. The results showed that, in particular, compliance, confidence in the safety of vaccines, whether parents have been vaccinated against COVID-19 themselves, trust in the governmental system, fear of COVID-19, and the parents’ age were directly related to the acceptance of the COVID-19 vaccine for children. To increase compliance and confidence in the vaccines’ safety among parents, promotion campaigns should provide more information concerning the vaccines’ safety, particularly for younger parents who are not vaccinated against COVID-19 themselves.

show abstract

Section: Introductionmentioning

confidence: 99%

COVID-19 Vaccine for Children: Vaccination Willingness of Parents and Its Associated Factors—A Network Analysis

et al. 2022

View full text Add to dashboard Cite

show abstract

“… 18 Vaccine resistance (refusal) is defined as those people who will definitely not be willing to get vaccinated; vaccine hesitancy is people who are uncertain whether to become vaccinated. 27 , 28 There are three types of vaccines available in Iraq which were included in the present study. These are Pfizer which is an mRNA subtype vaccine, AstraZeneca is an adenovirus subtype 29 and Sinopharm is an inactivated whole virus subtype.…”

Section: Discussionmentioning

confidence: 99%

Knowledge, Attitudes, and Practices of Adult Iraqi Population Towards COVID-19 Booster Dose: A Cross-Sectional Study

Al‐Qerem¹,

Jarab²,

Hammad³

et al. 2022

PPA

View full text Add to dashboard Cite

Purpose COVID-19 vaccines are critical for containing the pandemic and preventing serious SARS-CoV-2 infections. In addition to the two main doses, a booster dose has been utilized to improve immunity. The aim of current study is to evaluate Iraqi adult population knowledge, attitudes, and practices towards COVID-19 booster dose. Subjects and Methods This online cross-sectional survey of adult Iraqis (n = 754) assessed the attitudes of people who have had both immunizations regarding a potential COVID-19 vaccine booster dosage and to identify potential factors that might impact these attitudes. Factors evaluated in the current study included previously received vaccine type in the first two doses, socioeconomic characteristics, health status, knowledge about COVID-19 and its vaccines and adherence to protective practices. Results Overall, 61.1% of participants expressed willingness to receive a COVID-19 booster dose, with a high median score of knowledge and practice toward COVID-19. Participants who did not perceive COVID-19 to be serious, p -value <0.001), participants who believed they would not be infected with COVID-19 in the next 6 months ( p -value <0.001), low knowledge score group ( p -value <0.001), lower education ( p -value <0.001), participants who received the COVID-19 vaccine because of imposed laws ( p -value <0.001), participants who received AstraZeneca vaccine ( p -value <0.001), younger participants ( p -value=0.003), low level of practice ( p -value <0.001), participants who did not know someone who had died due to COVID-19 ( p -value=0.01), low risk of developing serious side effects if infected with COVID-19 and participants in the low side effects score were significantly less frequently willing to receive a booster COVID-19 dose ( p -value <0.001). The main reasons for booster dose hesitancy/refusal were the perceived lack of need for a booster shot, the uselessness of a booster shot and the conspiracy theory of boosting corporate profits through booster shots. Conclusion There is high hesitancy towards COVID-19 booster dose acceptance among the Iraqi population. The study identified several factors associated with vaccine hesitancy including low socioeconomic status and low knowledge about COVID-19 and its vaccines.

show abstract

“…COVID-19 patients also exhibited a higher risk of systemic complications that include cardiovascular system (myocardial infarction, myocarditis), cerebrovascular events (hemorrhagic infarctions, encephalopathy), and thromboembolic events. The COVID-19 patients’ often presented with significant co-morbidities that included diabetes, hypertension, obesity, and a previous episode of ischemic heart disease ( Umakanthan and Lawrence, 2022 ). A retrospective study conducted in China, revealed that out of 173 severe COVID-19 patients, the prevalence of hypertension, diabetes mellitus, coronary vascular disease, and cerebrovascular disease was significantly higher than non-severe diseases ( Guan et al, 2020 ).…”

Section: Introductionmentioning

confidence: 99%

The Effect of Statins on Clinical Outcome Among Hospitalized Patients With COVID-19: A Multi-Centric Cohort Study

Umakanthan

Senthil²,

John

et al. 2022

Front. Pharmacol.

Self Cite

View full text Add to dashboard Cite

The coronavirus disease-2019 (COVID-19) is caused by SARS-CoV-2, leading to acute respiratory distress syndrome (ARDS), thrombotic complications, and myocardial injury. Statins, prescribed for lipid reduction, have anti-inflammatory, anti-thrombotic, and immunomodulatory properties and are associated with reduced mortality rates in COVID-19 patients. Our goal was to investigate the beneficial effects of statins in hospitalized COVID-19 patients admitted to three multi-specialty hospitals in India from 1 June 2020, to 30 April 2021. This retrospective study included 1,626 patients, of which 524 (32.2%) were antecedent statin users among 768 patients (384 statin users, 384 non-statin users) identified with 1:1 propensity-score matching. We established a multivariable logistic regression model to identify the patients’ demographics and adjust the baseline clinical and laboratory characteristics and co-morbidities. Statin users showed a lower mean of white blood cell count (7.6 × 103/µL vs. 8.1 × 103/µL, p < 0.01), and C-reactive protein (100 mg/L vs. 120.7 mg/L, p < 0.001) compared to non-statin COVID-19 patients. The same positive results followed in lipid profiles for patients on statins. Cox proportional-hazards regression models evaluated the association between statin use and mortality rate. The primary endpoint involved mortality during the hospital stay. Statin use was associated with lower odds of mortality in the propensity-matched cohort (OR 0.52, 95% CI 0.33-0.64, p < 0.001). These results support the previous evidence of the beneficial effects of statins in reducing mortality in hospitalized COVID-19 patients.

show abstract

Retracted: Predictors of COVID-19 vaccine hesitancy in Germany: a cross-sectional, population-based study

Cited by 66 publications

References 48 publications

COVID-19 Vaccine for Children: Vaccination Willingness of Parents and Its Associated Factors—A Network Analysis

COVID-19 Vaccine for Children: Vaccination Willingness of Parents and Its Associated Factors—A Network Analysis

Knowledge, Attitudes, and Practices of Adult Iraqi Population Towards COVID-19 Booster Dose: A Cross-Sectional Study

The Effect of Statins on Clinical Outcome Among Hospitalized Patients With COVID-19: A Multi-Centric Cohort Study

Contact Info

Product

Resources

About